-
CROs & Outsourced R&D Projects
-
Key Benefits of Attending
This intensive course will deliver specific methodology and management techniques to successfully outsource pharmaceutical programs that are completed on time, within budget, and most importantly with a high level of quality and performance. This workshop will enable you to:
- Gain an in depth perspective focused on the components of performance and quality based management of drug development
- Understand how the current external and internal forces are shaping the way projects will need to be delivered to be competitive and cost efficient
- Define and implement meaningful metrics into the process
- Gather/analyze data to proactively deliver quality studies
Who Should Attend
This course has been specifically designed for:
Professionals in the Pharmaceutical, Biotechnology, Medical Device and Biologics industries who use Contract Research Organizations (CROs) in the process of developing their products for regulatory and FDA approvals.
Attendees should have a basic knowledge of drug, device or biologics development processes and a need to understand what is involved in outsourcing non-clinical and clinical research to CROs. VPs, Directors, Managers and other pharmaceutical personnel involved in managing and selecting CROs will benefit from this course.
From the following industries: Pharmaceuticals, Biotechnology/ Biopharmaceuticals, Drug Discovery & Development, Life Sciences, Contract Research Organisations (CROs) and Hospitals/ Research Centers
Course Instructor
Eric Morfin, MBA, PMP, PhD – Founder, BioPharmaPM & Partner, Critical Skills
With over 27 years of leadership and managerial experience in Life Sciences, Eric has led many departments, such as Project Management, QA/QC, Data Management, Operations, Clinical Trials for companies including Merck, Novartis, Pfizer, GSK, Roche, Aventis, BMS, Amylin, the National Cancer Institute, Astrazeneca, the FDA, Quintiles, Parexel, PPD and Genentech.
